NCT07502066Active, not recruiting
Clinical Efficacy of a telerehabilItation Protocol, for the Improvement of Balance in Degenerative Neurological Diseases
Source: ClinicalTrials.gov · Last updated 30 Mar 2026
Brief summary (registry, in English)
The goal of this one blind-randomized controlled clinical trial is to evaluate the clinical effectiveness of a telerehabilitation (TR) protocol focusing on balance rehabilitation in patients with neurodegenerative diseases (Parkinson's Disease, Multiple Sclerosis). The secondary objectives of the study are: 1. To evaluate the effects of clinical treatment on Health-Related Quality of Life (HRQOL) outcomes. 2. To collect data on process measures: user needs (patients and caregivers), treatment adherence, usability, satisfaction, technological acceptance. Participants will perform 20 rehabilitation session (physiotherapy) for balance improvement. Experimental group patients will be trheated through tele-rehabilitation performing exercise with an hospital physiotherapist. Researchers will compare telerehabilitation group to usual care group to see if there is a significant improvement in motor function, particularly in balance and mobility tests, as well as an improvement in quality of life.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- First submitted
- 17 Mar 2023
- Start date
- 14 Oct 2021
- Primary completion date
- Dec 2026
- Lead sponsor
- IRCCS San Camillo, Venezia, Italy
- Diseases
- Parkinson disease, Multiple sclerosis
- NCT number
- NCT07502066
What you commit to
- Study type: Interventional
- Planned participants: 36
- From 14 Oct 2021 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- All patients will be excluded from the study who, in association with the diagnosis of the diseases listed above, have the following comorbidities diagnosed and documented in the medical records
- Dementia;
- Epilepsy not controlled pharmacologically;
- Severe impairment of verbal comprehension
Other
- Unstabilised fractures;
- Diagnosis of major depression;
- Severe deficits in visual acuity and hearing perception;
- Ideomotor apraxia;
- Neglect;
Who the study is looking for
- Possession of an ADSL internet connection with a flat rate or, in the case of a pay-as-you-go tariff, with an availability of at least 20 Gigabytes/month.
- PARKINSON'S DISEASE:
- Patients with Parkinson's disease, according to the criteria of the UK Parkinson's Disease Society Brain Bank, in stabilised pharmacological treatment with L-Dopa or dopamine agonists and with a Hoehn \& Yahr scale score between 1.5 and 2.5;
- Patients presenting a score ≤ 2 in the 'freezing when walking' subitem of section II of the UPDRS;
- Patients presenting a score ≤ 2 in both duration and disability in the "dyskinesias" sub-item of section IV of the UPDRS.
- MULTIPLE SCLEROSIS
- Subjects with Multiple Sclerosis (MS) in the relapsing remitting (RRMS) or secondary progressive (SPMS) forms, according to the criteria of MC Donald 2010 \[14\], under stable drug treatment and with Expanded Disability Status Scale (EDSS) score ≤ 6.5;
- At the time of inclusion, at least 3 months have elapsed since the last relapse.
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS San Camillo Hospital Coordinator of this site? Confirm its status | Venice-Lido | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.